The purpose of the study is is to determine the effect, on the lung circulation, of BQ-123, an investigational compound which is not approved by the FDA.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pulmonary Vascular Resistance (PVR)
Timeframe: Baseline and time points 2, 3, 4, and 5 (as described in Outcome Measure Description)